Opicapone: A Review in Parkinson's Disease (vol 76, pg 1293, 2016)

Scott Lesley J.

首页> 外文期刊>Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts >Opicapone: A Review in Parkinson's Disease (vol 76, pg 1293, 2016)

【24h】

Opicapone: A Review in Parkinson's Disease (vol 76, pg 1293, 2016)

机译：Opicapone：帕金森病的评论（Vol 76，PG 1293,2016）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Parkinson's disease (PD) is the most common chronic, progressive, neurodegenerative disease, with a mean age of onset of 57 years [1, 2].

机译：帕金森病（PD）是最常见的慢性，进行，神经退行性疾病，平均年龄为57岁[1,2]。

著录项

来源
《Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts》 |2018年第1期|共2页
作者
Scott Lesley J.;
展开▼
作者单位

Springer Private Bag 65901 Auckland 0754 New Zealand;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Opicapone: A Review in Parkinson's Disease (vol 76, pg 1293, 2016) [J] . Scott Lesley J. Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts . 2018,第1期

机译：Opicapone：帕金森病的评论（Vol 76，PG 1293,2016）
2. Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management (vol 76, pg 1093, 2016) [J] . Chang Anna, Fox Susan H. Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts . 2016,第13期

机译：帕金森氏病中的精神病：流行病学，病理生理学和管理（第76卷，第1093页，2016年）
3. Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biologic disease-modifying antirheumatic drugs (vol 75, pg 1293, 2016) [J] . Charles-Schoeman C., Burmester G., Nash P. Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2017,第3期

机译：对常规合成或生物疾病改性抗腹性药物不充分应对（Vol 75，PG 1293,2016）后，Tofacitinib的疗效和安全性
4. Connectome Pathways in Parkinson's Disease Patients with Deep Brain Stimulators Connectome Pathways in Parkinson's Disease Patients with DBS [C] . Giorgio Bonmassar, Nikos Makris International Conference on Advanced Cognitive Technologies and Applications . 2015

机译：Connectome途径在帕金森病患者深脑刺激患者帕金森病患者DBS的疾病患者
5. Examining the Relationship Between Mitochondrial Dysfunction and Parkinson's Disease Pathology: A Review on Potential Risk Factors and Treatments for Parkinsonism [D] . Bonilla, Harrison. 2019

机译：检查线粒体功能障碍与帕金森氏病病理之间的关系：帕金森氏症的潜在危险因素和治疗方法的综述
6. Clinical Utility of Opicapone in the Management of Parkinson’s Disease: A Short Review on Emerging Data and Place in Therapy [O] . Linda Azevedo Kauppila, Daniela Pimenta Silva, Joaquim J Ferreira 2021

机译：Opicapone在帕金森病管理中的临床效用：治疗中新兴数据及地点的简短综述
7. Clinical Utility of Opicapone in the Management of Parkinson’s Disease: A Short Review on Emerging Data and Place in Therapy [O] . Linda Azevedo Kauppila, Daniela Pimenta Silva, Joaquim J Ferreira 2021

机译：Opicapone在帕金森病管理中的临床效用：治疗中新兴数据及地点的简短综述

Opicapone: A Review in Parkinson's Disease (vol 76, pg 1293, 2016)

摘要

著录项

相似文献

相关主题

期刊订阅